Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castrate-resistant Metastatic Prostate Cancer”

219 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 219 results

Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Testing effectiveness (Phase 2)Looking for participantsNCT06001255
What this trial is testing

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Who this might be right for
Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company 120
Testing effectiveness (Phase 2)Looking for participantsNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 110
Testing effectiveness (Phase 2)Ended earlyNCT01338012
What this trial is testing

Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 8
Testing effectiveness (Phase 2)Study completedNCT02105675
What this trial is testing

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
SOTIO a.s. 60
Testing effectiveness (Phase 2)Ended earlyNCT01717898
What this trial is testing

Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Charles Ryan 6
Testing effectiveness (Phase 2)WithdrawnNCT01530984
What this trial is testing

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Lawrence Fong
Testing effectiveness (Phase 2)Study completedNCT03456804
What this trial is testing

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 13
Large-scale testing (Phase 3)Study completedNCT05547386
What this trial is testing

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 163
Testing effectiveness (Phase 2)Active Not RecruitingNCT02881242
What this trial is testing

Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 14
Very early researchStudy completedNCT02391025
What this trial is testing

Gallium-68 Citrate PET Used in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Rahul Aggarwal 39
Early research (Phase 1)Study completedNCT03751436
What this trial is testing

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+6 more
Roswell Park Cancer Institute 10
Large-scale testing (Phase 3)Study completedNCT01824342
What this trial is testing

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Amgen 18
Testing effectiveness (Phase 2)Looking for participantsNCT06702995
What this trial is testing

Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)
Evopoint Biosciences Inc. 307
Early research (Phase 1)Ended earlyNCT02500901
What this trial is testing

Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Prostate Cancer
Paul Mathew, MD 2
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Large-scale testing (Phase 3)Ended earlyNCT02438007
What this trial is testing

Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 953
Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Load More Results